Crossref
Semaglutide Improves Heart Failure and Cardiovascular Disease
JAMA · 26.09.2023 · 330 (12) · 1127
DOI: 10.1001/jama.2023.16674 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 26.09.2023. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Glucagon-Like Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Cardiovascular DiseasesGlucagon-Like PeptidesHumansHeart FailureSemaglutide
Substanzen
Glucagon-Like PeptidesSemaglutide
Zitieren
APA
Harris, E. (2023). Semaglutide Improves Heart Failure and Cardiovascular Disease. JAMA, 330(12), 1127. https://doi.org/10.1001/jama.2023.16674
Vancouver
Harris E. Semaglutide Improves Heart Failure and Cardiovascular Disease. JAMA. 2023;330(12):1127. doi:10.1001/jama.2023.16674
BibTeX
@article{Harris2023,
author = {Harris, Emily},
title = {Semaglutide Improves Heart Failure and Cardiovascular Disease},
journal = {JAMA},
year = {2023},
volume = {330},
number = {12},
pages = {1127},
doi = {10.1001/jama.2023.16674}
}
EUVIMED